T4 report. An expert consortium review of the EC-commissioned report "Alternative (non-animal) methods for cosmetics testing: Current status and future prospects - 2010"

Altex

Volumn 28, Issue 3, 2011, Pages 183-209

  Hartung, Thomas ^a,b   Blaauboer, Bas J ^c   Bosgra, Sieto ^d   Carney, Edward ^e   Coenen, Joachim ^f   Conolly, Rory B ^g   Corsini, Emanuela ^h   Green, Sidney ⁱ   Faustman, Elaine M ^j   Gaspari, Anthony ^k   Hayashi, Makoto ^l   Hayes, A Wallace ^m   Hengstler, Jan G ⁿ   Knudsen, Lisbeth E ^o   Knudsen, Thomas B ^g   McKim, James M ^p   Pfaller, Walter ^q   Roggen, Erwin L ^r  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF KONSTANZ   (Germany)

^c UTRECHT UNIVERSITY   (Netherlands)

^d TNO   (Netherlands)

^e DOW CHEMICAL COMPANY   (United States)

^f Merck Serono GmbH   (Germany)

^g U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^h UNIVERSITY OF MILAN   (Italy)

ⁱ HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^j UNIVERSITY OF WASHINGTON   (United States)

^k UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^l Biosafety Research Center   (Japan)

^m HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

ⁿ TU DORTMUND UNIVERSITY   (Germany)

^o UNIVERSITY OF COPENHAGEN   (Denmark)

^p CeeTox Inc   (United States)

^q INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^r NOVOZYMES A S   (Denmark)

more..

Author keywords

3Rs; Alternatives to animal testing; Novel approaches; Product safety; Toxicology

Indexed keywords

COSMETIC;

BRAIN; CARCINOGEN TESTING; COSMETIC INDUSTRY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EXCRETION; DRUG METABOLISM; EXPERIMENTAL ANIMAL; IMMUNOTOXICITY; LIVER; LUNG; NONHUMAN; PRODUCT SAFETY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW; RISK ASSESSMENT; SENSITIZATION; TOXICOKINETICS; ANIMAL; ANIMAL TESTING ALTERNATIVE; ARTICLE; EUROPEAN UNION; EXPERT WITNESS; METHODOLOGY; STANDARD; TOXICITY TESTING;

ANIMAL TESTING ALTERNATIVES; ANIMALS; COSMETICS; EUROPEAN UNION; EXPERT TESTIMONY; TOXICITY TESTS;

EID: 80053546181     PISSN: 09467785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Adler, S., Basketter, D., Cretan, S., et al. (2011). Alternative (non-animal) methods for cosmetics testing: current status and future prospects-2010. Arch. Toxicol. 85, 367-485.
2. Aydin, S., Signorelli, S., Lechleitner, T., et al. (2008). Influence of microvascular endothelial cells on transcriptional regulation of proximal tubular epithelial cells. Am. J. Physiol. Cell. Physiol. 294, C543-54. (Pubitemid 351264421)
3. Carfi', M., Gennari, A., Malerba, I., et al. (2007). In vitro tests to evaluate immunotoxicity: a preliminary study. Toxicology 229, 11-22.
4. Corsini, E., and Roggen, E. L. (2009). Immunotoxicology: opportunities for non-animal test development. ATLA 37, 387-397.
5. Delarue, F., Virone, A., Hagege, J., et al. (1991). Stable cell line of T-SV40 immortalized human glomerular visceral epithelial cells. Kidney Int. 40, 906-912.
6. Emter, R., Ellis, G., and Natsch, A. (2010). Performance of a novel keratinocyte-based reporter cell line to screen skin sensitizers in vitro. Toxicol. Appl. Pharmacol. 245, 281-290.
7. Eskes, C., and Zuang, V. (2005). Alternative (non-animal) methods for cosmetic testing: current status and future prospects. ATLA 33, Suppl. 1, 1-228.
8. European Commission (2003). Directive 2003/15/EC of the European Parliament and of the Council of 27 February 2003 amending Council Directive 76/768/EEC on the approximation of the laws of the Member States relating to cosmetic products. Official J. Eur. Union of 11.3.2003, L66, 26-35.
9. European Commission (2009). Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products. Official J. Eur. Union of 30.11.2009, L342, 59-209.
10. Gennari, A., Ban, M., Braun, A., et al. (2005). The use of in vitro systems for evaluating immunotoxicity: The report and recommendations of an ECVAM workshop. J. Immunotoxicol. 2, 61-83. (Pubitemid 41702862)
11. Galbiati, V., Mitjans, M., and Corsini, E. (2010). Present and future of in vitro immunotoxicology in drug development. J. Immuntoxicol. 7, 255-267.
12. Gerbenck, G. F., Vassallo, J. D., Foertsch, L. M., et al. (2007). Quantification of chemical peptide reactivity for screening contact allergens: A classification tree model approach. Toxicol. Sci. 97, 417-427. (Pubitemid 47073857)
13. Gilbert, N. (2011). Data gaps threaten chemical safety law. Nature 475, 150-151.
14. Hartung, T., Bremer, S., Casati, S., et al. (2003). ECVAM's response to the changing political environment for alternatives: Consequences of the European Union chemicals and cosmetics policy. ATLA 31, 473-481. (Pubitemid 38004883)
15. Hartung, T. (2008). Food for thought ... on alternative methods for cosmetics safety testing. ALTEX 25, 147-162.
16. Hayashi, M., Kamata, E., Hirose, A., et al. (2005) In silico assessment of chemical mutagenesis in comparison with results of Salmonella microsome assay on 909 chemicals. Mutat. Res. 588, 129-135. (Pubitemid 41785734)
17. Hochstenbach, K., van Leeuwen, D. M., Gmuender, H., et al. (2010). Transcriptomic profile indicative of immunotoxic exposure: in vitro studies in peripheral blood mononuclear cells. Toxicol. Sci. 118, 19-30.
18. Kleinstreuer, N. C., Judson, R. S., Reif, D. M., et al. (2011). Environmental impact on vascular development predicted by high throughput screening. Environ. Health. Perspect., Epub ahead of print.
19. Knudsen, T. B., Martin, M. T., Kavlock, R. J., et al. (2009). Profiling the activity of environmental chemicals in prenatal developmental toxicity studies using the U. S. EPA's ToxRefDB. Reprod. Toxicol. 28, 209-219.
20. Koeper, L. M., and Vohr, H. W. (2009). Functional assays are mandatory for correct prediction of immunotoxic properties of compounds in vitro. Food Chem. Toxicol. 47, 110-118.
21. Langezaal, I., Coecke, S., and Hartung, T. (2001). Whole blood cytokine response as a measure of immunotoxicity. Toxicol. In Vitro 15, 313-318. (Pubitemid 32889650)
22. Langezaal, I., Hoffmann, S., Hartung, T., and Coecke, S. (2002). Evaluation and prevalidation of an immunotoxicity test based on human whole-blood cytokine release. ATLA 30, 581-595. (Pubitemid 36168750)
23. Lankveld, D. P. K., van Loveren, H., Baken, K. A., and Vandebriel, R. J. (2010). In vitro testing for direct immunotoxicity: state of the art. In Dietrich, D. (ed.) Immunotoxicity Testing, Methods in Molecular Biology, 2010, Volume 598, Part 7, (401-423) Humana Press, New York, USA.
24. Martin, M. T., Judson, R. S., Reif, D. M., et al. (2009a). Profiling chemicals based on chronic toxicity results from the U.S. EPA ToxRef Database. Environ. Health Perspect. 117, 392-399.
25. Martin, M. T., Mendez, E., Coram, D. G., et al. (2009b). Profiling the reproductive toxicity of chemicals from multigeneration studies in the toxicity reference database. Toxicol. Sci. 110, 181-190.
26. Martin, M. T., Knudsen, T. B., Reif, D. M., et al. (2011). Predictive model of rat reproductive toxicity from ToxCast high throughput screening. Biol. Reprod. 85, 327-339.
27. Mathiesen, L., Mose, T., Mørck, T. J., et al. (2010). Quality assessment of a placental perfusion protocol. Reprod. Toxicol. 30, 138-146.
28. McKim, J.M. (2010). Building a tiered approach to in vitro predictive toxicity screening: a focus on assays with in vivo relevance. Comb. Chem. High Throughput Screen. 13, 188-206.
29. Mitjans, M., Viviam, B., Lucchi, L., et al. (2008). Role of p38 MAPK in the selective release of IL-8 induced by chemical allergen in naive THP-1 cells. Toxicol. In Vitro 22, 386-395. (Pubitemid 351163546)
30. Myllynen, P., Mathiesen, L., Weimer, M., et al. (2010). Preliminary interlaboratory comparison of the ex vivo dual human placental perfusion system. Reprod. Toxicol. 30, 94-102.
31. Nakanishi, T., Turner, R. J., and Burg, M. B. (1989). Osmoregulatory changes in myo-inositol transport by renal cells. Proc. Natl. Acad. Sci. 86, 6002-6006. (Pubitemid 19217574)
32. Natsch, A., and Emter, R. (2008). Skin sensitizers induce antioxidant response element dependent genes: application to the in vitro testing of the sensitization potential of chemicals. Toxicol. Sci. 102, 110-119. (Pubitemid 351250473)
33. Nguyen, G., Delarae, F., Berrou, J., et al. (1996). Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int. 50, 1897-1903. (Pubitemid 26417532)
34. Paules, R. S., Aubrecht, J., Corvi, R. (2011). Moving forward in human cancer risk assessment. Environ. Health Perspect. 119, 739-743.
35. Peyret, T., Poulin, P., and Krishnan, K. (2010). A unified algorithm for predicting partition coefficients for PBPK modeling of drugs and environmental chemicals. Toxicol. Appl. Pharmacol. 249, 197-207.
36. Pfuhler, S., Kirkland, D., Kasper, P., et al. (2009). Reduction of use of animals in regulatory genotoxicity testing: Identification and implementation opportunities - Report from an ECVAM workshop. Mut. Res. 680, 31-42.
37. Ringerike, T., Ullerås, E., Völker, R., et al. (2005). Detection of immunotoxicity using T-cell-based cytokine reporter cell lines ("Cell Chip"). Toxicology 206, 257-272. (Pubitemid 39601037)
38. Robinson, J. F., Theunissen, P., van Dartel, D., et al. (2011). Comparison of MeHg-induced toxicogenomic responses across in vivo and in vitro models used in developmental toxicology. Reprod. Toxicol., in press.
39. Sakaguchi, H., Ashikaga, T., Miyazawa, M., et al. (2009). The relationship between CD86/CD54 expression and THP-1 cell viability in an in vitro skin sensitization test - human cell line activation test (h-CLAT). Cell. Biol. Toxicol. 25, 109-126.
40. Sarrab, R. M., Lennon, R., Ni, L., et al. (2011). Establishment of conditionally immortalised human glomerular mesangial cells in culture, with unique migratory properties. Am. J. Physiol. Renal Physiol., Epub ahead of print.
41. Sipes, N. S., Martin, M. T., Reif, D. M., et al. (2011). Predictive models of prenatal developmental toxicity from ToxCast high-throughput screening data. Toxicol. Sci., in press.
42. Verwei, M., van Burgsteden, J. A., Krul, C. A., et al. (2006). Prediction of in vivo embryotoxic effect levels with a combination of in vitro studies and PBPK modelling. Toxicol. Lett. 165, 79-87. (Pubitemid 43867181)
43. Wieser, M., Stadler, G., Jennings, P., et al. (2008). hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics. Am. J. Physiol. Renal. Physiol. 295, F1365-F1375.
44. Yu, X., Hong, S., Moreira, E. G., and Faustman, E. M. (2009). Improving in vitro Sertoli cell/gonocyte co-culture model for assessing male reproductive toxicity: Lessons learned from comparisons of cytotoxicity versus genomic responses to phthalates. Toxicol. Appl. Pharmacol. 15, 325-336.
45. Yu, X., Robinson, J. F., Sidhu, J. S., et al. (2010). A system-based comparison of gene expression reveals alterations in oxidative stress, disruption of ubiquitin-proteasome system and altered cell cycle regulation after exposure to cadmium and methylmercury in Mouse Embryonic Fibroblast (MEF). Toxicol. Sci. 114, 356-377.
46. Yu, X., Sidhu, J. S., Hong, S., et al. (2011). Cadmium induced p53-dependent activation of stress signaling, accumulation of ubiquitinated proteins, and apoptosis in mouse embryonic fibroblast cells. Toxicol. Sci. 120, 403-412.
47. Zuang, V., and Hartung, T. (2005). Making validated alternatives available - the strategies and work of the European Centre for the Validation of Alternative Methods (ECVAM). AATEX 11, 15-26.